HEADER CHAPERONE 31-MAR-22 7ZET TITLE CRYSTAL STRUCTURE OF HUMAN CLUSTERIN, CRYSTAL FORM I COMPND MOL_ID: 1; COMPND 2 MOLECULE: CLUSTERIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CLU-DELTA(214-238); COMPND 5 SYNONYM: AGING-ASSOCIATED GENE 4 PROTEIN,APOLIPOPROTEIN J,APO-J, COMPND 6 COMPLEMENT CYTOLYSIS INHIBITOR,CLI,COMPLEMENT-ASSOCIATED PROTEIN SP- COMPND 7 40,40,KU70-BINDING PROTEIN 1,NA1/NA2,SULFATED GLYCOPROTEIN 2,SGP-2, COMPND 8 TESTOSTERONE-REPRESSED PROSTATE MESSAGE 2,TRPM-2; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLU, APOJ, CLI, KUB1, AAG4; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: STABLE GENOME INTEGRATION; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PB-T-PAF KEYWDS MOLECULAR CHAPERONE, COMPLEMENT SYSTEM, ALZHEIMER'S DISEASE, KEYWDS 2 CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR P.YUSTE-CHECA,A.BRACHER,F.U.HARTL REVDAT 1 11-OCT-23 7ZET 0 JRNL AUTH P.YUSTE-CHECA,A.BRACHER,F.U.HARTL JRNL TITL CRYSTAL STRUCTURE OF HUMAN CLUSTERIN, CRYSTAL FORM I JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2-4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.61 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 13814 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 701 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.6100 - 4.7800 0.98 2690 152 0.2092 0.2336 REMARK 3 2 4.7800 - 3.8000 0.99 2664 126 0.1989 0.2389 REMARK 3 3 3.8000 - 3.3200 0.98 2593 153 0.2394 0.3169 REMARK 3 4 3.3200 - 3.0200 0.98 2627 129 0.3183 0.3909 REMARK 3 5 3.0200 - 2.8000 0.96 2539 141 0.3565 0.4019 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.540 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 75.02 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 80.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE CLUSTERIN CONSTRUCT IS A GLYCO REMARK 3 -PROTEIN, WHICH WAS EXPRESSED IN THE PRESENCE OF THE ALPHA- REMARK 3 MANNOSIDASE I INHIBITOR KIFUNENSINE, WHICH PREVENTS TRIMMING OF REMARK 3 MANNOSE MOIETIES, RESULTING IN OLIGO-MANNOSE N-GLYCANS, AND REMARK 3 THEREBY PREVENTS PROCESSING TO MATURE COMPLEX N-GLYCANS (CHANG REMARK 3 ET AL., STRUCTURE 15, 267(2007), FIG. 1B). ASN RESIDUES 86, 103, REMARK 3 145, 291, 354 AND 374 ARE EXPECTED TO CARRY PREDOMINANTLY NAG- REMARK 3 NAG-BMA-(3->1)MAN-MAN-MAN (6->1)-MAN (3->1)MAN-MAN (6->1)MAN-MAN REMARK 3 N-GLYCAN TREES (CHANG ET AL., STRUCTURE 15, 267(2007), FIG. 1B). REMARK 4 REMARK 4 7ZET COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-APR-22. REMARK 100 THE DEPOSITION ID IS D_1292122144. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.77490 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS VERSION FEB 5, 2021 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13861 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 49.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.14600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 1.65600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP 11.4.06 REMARK 200 STARTING MODEL: ALPHAFOLD AF-P10909-F1-MODEL_V1.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG-4000, 0.2 M NH4-ACETATE, 0.1 M REMARK 280 NA-CITRATE PH 5.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.90400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 23 REMARK 465 GLN A 24 REMARK 465 HIS A 261 REMARK 465 PHE A 262 REMARK 465 HIS A 263 REMARK 465 SER A 264 REMARK 465 PRO A 265 REMARK 465 ALA A 266 REMARK 465 PHE A 267 REMARK 465 GLN A 268 REMARK 465 HIS A 269 REMARK 465 PRO A 270 REMARK 465 PRO A 271 REMARK 465 THR A 272 REMARK 465 GLU A 273 REMARK 465 PHE A 274 REMARK 465 ILE A 275 REMARK 465 ARG A 276 REMARK 465 GLU A 277 REMARK 465 GLY A 278 REMARK 465 ASP A 279 REMARK 465 ASP A 280 REMARK 465 ARG A 447 REMARK 465 GLU A 448 REMARK 465 GLU A 449 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 40 CG CD CE NZ REMARK 470 GLU A 97 CG CD OE1 OE2 REMARK 470 GLU A 104 CG CD OE1 OE2 REMARK 470 ARG A 198 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 213 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 241 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 245 CG CD OE1 NE2 REMARK 470 ARG A 282 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 289 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 297 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 422 CG CD OE1 OE2 REMARK 470 LYS A 429 CG CD CE NZ REMARK 470 GLU A 436 CG CD OE1 OE2 REMARK 470 LYS A 437 CG CD CE NZ REMARK 470 LYS A 444 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 129 -91.25 -90.45 REMARK 500 ARG A 130 -158.38 -157.99 REMARK 500 LEU A 296 0.76 -69.43 REMARK 500 SER A 396 -12.69 77.43 REMARK 500 REMARK 500 REMARK: NULL DBREF 7ZET A 23 449 UNP P10909 CLUS_HUMAN 23 449 SEQADV 7ZET A UNP P10909 ARG 214 DELETION SEQADV 7ZET A UNP P10909 ARG 215 DELETION SEQADV 7ZET A UNP P10909 PRO 216 DELETION SEQADV 7ZET A UNP P10909 HIS 217 DELETION SEQADV 7ZET A UNP P10909 PHE 218 DELETION SEQADV 7ZET A UNP P10909 PHE 219 DELETION SEQADV 7ZET A UNP P10909 PHE 220 DELETION SEQADV 7ZET A UNP P10909 PRO 221 DELETION SEQADV 7ZET A UNP P10909 LYS 222 DELETION SEQADV 7ZET A UNP P10909 SER 223 DELETION SEQADV 7ZET A UNP P10909 ARG 224 DELETION SEQADV 7ZET A UNP P10909 ILE 225 DELETION SEQADV 7ZET A UNP P10909 VAL 226 DELETION SEQADV 7ZET A UNP P10909 ARG 227 DELETION SEQADV 7ZET A UNP P10909 SER 228 DELETION SEQADV 7ZET A UNP P10909 LEU 229 DELETION SEQADV 7ZET A UNP P10909 MET 230 DELETION SEQADV 7ZET A UNP P10909 PRO 231 DELETION SEQADV 7ZET A UNP P10909 PHE 232 DELETION SEQADV 7ZET A UNP P10909 SER 233 DELETION SEQADV 7ZET A UNP P10909 PRO 234 DELETION SEQADV 7ZET A UNP P10909 TYR 235 DELETION SEQADV 7ZET A UNP P10909 GLU 236 DELETION SEQADV 7ZET A UNP P10909 PRO 237 DELETION SEQADV 7ZET A UNP P10909 LEU 238 DELETION SEQRES 1 A 402 ASP GLN THR VAL SER ASP ASN GLU LEU GLN GLU MET SER SEQRES 2 A 402 ASN GLN GLY SER LYS TYR VAL ASN LYS GLU ILE GLN ASN SEQRES 3 A 402 ALA VAL ASN GLY VAL LYS GLN ILE LYS THR LEU ILE GLU SEQRES 4 A 402 LYS THR ASN GLU GLU ARG LYS THR LEU LEU SER ASN LEU SEQRES 5 A 402 GLU GLU ALA LYS LYS LYS LYS GLU ASP ALA LEU ASN GLU SEQRES 6 A 402 THR ARG GLU SER GLU THR LYS LEU LYS GLU LEU PRO GLY SEQRES 7 A 402 VAL CYS ASN GLU THR MET MET ALA LEU TRP GLU GLU CYS SEQRES 8 A 402 LYS PRO CYS LEU LYS GLN THR CYS MET LYS PHE TYR ALA SEQRES 9 A 402 ARG VAL CYS ARG SER GLY SER GLY LEU VAL GLY ARG GLN SEQRES 10 A 402 LEU GLU GLU PHE LEU ASN GLN SER SER PRO PHE TYR PHE SEQRES 11 A 402 TRP MET ASN GLY ASP ARG ILE ASP SER LEU LEU GLU ASN SEQRES 12 A 402 ASP ARG GLN GLN THR HIS MET LEU ASP VAL MET GLN ASP SEQRES 13 A 402 HIS PHE SER ARG ALA SER SER ILE ILE ASP GLU LEU PHE SEQRES 14 A 402 GLN ASP ARG PHE PHE THR ARG GLU PRO GLN ASP THR TYR SEQRES 15 A 402 HIS TYR LEU PRO PHE SER LEU PRO HIS ASN PHE HIS ALA SEQRES 16 A 402 MET PHE GLN PRO PHE LEU GLU MET ILE HIS GLU ALA GLN SEQRES 17 A 402 GLN ALA MET ASP ILE HIS PHE HIS SER PRO ALA PHE GLN SEQRES 18 A 402 HIS PRO PRO THR GLU PHE ILE ARG GLU GLY ASP ASP ASP SEQRES 19 A 402 ARG THR VAL CYS ARG GLU ILE ARG HIS ASN SER THR GLY SEQRES 20 A 402 CYS LEU ARG MET LYS ASP GLN CYS ASP LYS CYS ARG GLU SEQRES 21 A 402 ILE LEU SER VAL ASP CYS SER THR ASN ASN PRO SER GLN SEQRES 22 A 402 ALA LYS LEU ARG ARG GLU LEU ASP GLU SER LEU GLN VAL SEQRES 23 A 402 ALA GLU ARG LEU THR ARG LYS TYR ASN GLU LEU LEU LYS SEQRES 24 A 402 SER TYR GLN TRP LYS MET LEU ASN THR SER SER LEU LEU SEQRES 25 A 402 GLU GLN LEU ASN GLU GLN PHE ASN TRP VAL SER ARG LEU SEQRES 26 A 402 ALA ASN LEU THR GLN GLY GLU ASP GLN TYR TYR LEU ARG SEQRES 27 A 402 VAL THR THR VAL ALA SER HIS THR SER ASP SER ASP VAL SEQRES 28 A 402 PRO SER GLY VAL THR GLU VAL VAL VAL LYS LEU PHE ASP SEQRES 29 A 402 SER ASP PRO ILE THR VAL THR VAL PRO VAL GLU VAL SER SEQRES 30 A 402 ARG LYS ASN PRO LYS PHE MET GLU THR VAL ALA GLU LYS SEQRES 31 A 402 ALA LEU GLN GLU TYR ARG LYS LYS HIS ARG GLU GLU HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG A 501 14 HET NAG A 502 14 HET NAG A 503 14 HET NAG A 504 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 NAG 8(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 HELIX 1 AA1 SER A 27 LYS A 40 1 14 HELIX 2 AA2 TYR A 41 GLU A 97 1 57 HELIX 3 AA3 GLU A 104 VAL A 128 1 25 HELIX 4 AA4 GLY A 132 GLN A 146 1 15 HELIX 5 AA5 SER A 148 MET A 154 1 7 HELIX 6 AA6 ASN A 155 PHE A 191 1 37 HELIX 7 AA7 GLN A 192 THR A 197 5 6 HELIX 8 AA8 GLU A 199 TYR A 204 5 6 HELIX 9 AA9 PHE A 240 ASP A 259 1 20 HELIX 10 AB1 ARG A 282 ASN A 291 1 10 HELIX 11 AB2 SER A 292 LYS A 299 5 8 HELIX 12 AB3 CYS A 302 LEU A 309 1 8 HELIX 13 AB4 ASN A 317 GLN A 377 1 61 HELIX 14 AB5 VAL A 421 ARG A 425 1 5 HELIX 15 AB6 LYS A 429 HIS A 446 1 18 SHEET 1 AA1 3 LEU A 384 SER A 391 0 SHEET 2 AA1 3 VAL A 402 LEU A 409 -1 O LYS A 408 N ARG A 385 SHEET 3 AA1 3 ILE A 415 PRO A 420 -1 O ILE A 415 N VAL A 407 SSBOND 1 CYS A 102 CYS A 313 1555 1555 2.04 SSBOND 2 CYS A 113 CYS A 305 1555 1555 2.03 SSBOND 3 CYS A 116 CYS A 302 1555 1555 2.03 SSBOND 4 CYS A 121 CYS A 295 1555 1555 2.02 SSBOND 5 CYS A 129 CYS A 285 1555 1555 2.03 LINK ND2 ASN A 86 C1 NAG A 501 1555 1555 1.44 LINK ND2 ASN A 103 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN A 145 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN A 291 C1 NAG A 502 1555 1555 1.44 LINK ND2 ASN A 354 C1 NAG A 503 1555 1555 1.43 LINK ND2 ASN A 374 C1 NAG A 504 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.45 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.45 CRYST1 65.742 43.808 102.800 90.00 107.29 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015211 0.000000 0.004735 0.00000 SCALE2 0.000000 0.022827 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010188 0.00000